These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 35108705)

  • 1. Baseline Levels of Retinol-Binding Protein 4 and Vitamin A in Healthy Subjects, Stargardt Disease, and Geographic Atrophy Patients.
    Janeschitz-Kriegl L; Cattaneo M; Scholl HPN
    Ophthalmic Res; 2022; 65(3):351-360. PubMed ID: 35108705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A non-retinoid antagonist of retinol-binding protein 4 rescues phenotype in a model of Stargardt disease without inhibiting the visual cycle.
    Racz B; Varadi A; Kong J; Allikmets R; Pearson PG; Johnson G; Cioffi CL; Petrukhin K
    J Biol Chem; 2018 Jul; 293(29):11574-11588. PubMed ID: 29871924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, synthesis, and evaluation of nonretinoid retinol binding protein 4 antagonists for the potential treatment of atrophic age-related macular degeneration and Stargardt disease.
    Cioffi CL; Dobri N; Freeman EE; Conlon MP; Chen P; Stafford DG; Schwarz DM; Golden KC; Zhu L; Kitchen DB; Barnes KD; Racz B; Qin Q; Michelotti E; Cywin CL; Martin WH; Pearson PG; Johnson G; Petrukhin K
    J Med Chem; 2014 Sep; 57(18):7731-57. PubMed ID: 25210858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A1120, a nonretinoid RBP4 antagonist, inhibits formation of cytotoxic bisretinoids in the animal model of enhanced retinal lipofuscinogenesis.
    Dobri N; Qin Q; Kong J; Yamamoto K; Liu Z; Moiseyev G; Ma JX; Allikmets R; Sparrow JR; Petrukhin K
    Invest Ophthalmol Vis Sci; 2013 Jan; 54(1):85-95. PubMed ID: 23211825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bicyclic [3.3.0]-Octahydrocyclopenta[c]pyrrolo Antagonists of Retinol Binding Protein 4: Potential Treatment of Atrophic Age-Related Macular Degeneration and Stargardt Disease.
    Cioffi CL; Racz B; Freeman EE; Conlon MP; Chen P; Stafford DG; Schwarz DM; Zhu L; Kitchen DB; Barnes KD; Dobri N; Michelotti E; Cywin CL; Martin WH; Pearson PG; Johnson G; Petrukhin K
    J Med Chem; 2015 Aug; 58(15):5863-88. PubMed ID: 26181715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum retinol-binding protein 4 concentration and its ratio to serum retinol are associated with obesity and metabolic syndrome components in children.
    Aeberli I; Biebinger R; Lehmann R; L'allemand D; Spinas GA; Zimmermann MB
    J Clin Endocrinol Metab; 2007 Nov; 92(11):4359-65. PubMed ID: 17726085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum retinol binding protein 4 level is related with renal functions in Type 2 diabetes.
    Akbay E; Muslu N; Nayir E; Ozhan O; Kiykim A
    J Endocrinol Invest; 2010 Nov; 33(10):725-9. PubMed ID: 20436266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does Retinol-Binding Protein 4 (holo- and apo-RBP4) Increase or Remain Constant in Sera from Patients with Hypothyroidism?
    Kiuchi S; Ihara H; Sega M; Tani A; Nishiguchi Y; Hashizume N
    J Nutr Sci Vitaminol (Tokyo); 2023; 69(6):412-419. PubMed ID: 38171813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of Bispecific Antagonists of Retinol Binding Protein 4 That Stabilize Transthyretin Tetramers: Scaffolding Hopping, Optimization, and Preclinical Pharmacological Evaluation as a Potential Therapy for Two Common Age-Related Comorbidities.
    Cioffi CL; Muthuraman P; Raja A; Varadi A; Racz B; Petrukhin K
    J Med Chem; 2020 Oct; 63(19):11054-11084. PubMed ID: 32878437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Significantly Reduced Retinol Binding Protein 4 (RBP4) Levels in Critically Ill COVID-19 Patients.
    Vollenberg R; Tepasse PR; Fobker M; Hüsing-Kabar A
    Nutrients; 2022 May; 14(10):. PubMed ID: 35631143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigation of oral fenretinide for treatment of geographic atrophy in age-related macular degeneration.
    Mata NL; Lichter JB; Vogel R; Han Y; Bui TV; Singerman LJ
    Retina; 2013 Mar; 33(3):498-507. PubMed ID: 23023528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relative dose response test based on retinol-binding protein 4 is not suitable to assess vitamin A status in very low birth weight infants.
    Schmiedchen B; Longardt AC; Bührer C; Raila J; Loui A; Schweigert FJ
    Neonatology; 2014; 105(2):155-60. PubMed ID: 24356375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of the vitamin A transport in preterm infants after repeated high-dose vitamin A injections.
    Longardt AC; Schmiedchen B; Raila J; Schweigert FJ; Obladen M; Bührer C; Loui A
    Eur J Clin Nutr; 2014 Dec; 68(12):1300-4. PubMed ID: 25315494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic Kidney Disease Alters Vitamin A Homeostasis via Effects on Hepatic RBP4 Protein Expression and Metabolic Enzymes.
    Jing J; Isoherranen N; Robinson-Cohen C; Petrie I; Kestenbaum BR; Yeung CK
    Clin Transl Sci; 2016 Aug; 9(4):207-15. PubMed ID: 27277845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic Importance of Vitamins A, E and Retinol-binding Protein 4 in Renal Cell Carcinoma Patients.
    Sobotka R; Čapoun O; Kalousová M; Hanuš T; Zima T; Koštířová M; Soukup V
    Anticancer Res; 2017 Jul; 37(7):3801-3806. PubMed ID: 28668878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of Retinol Binding Protein 4 and
    Chou HD; Hwang YS; Chen KJ; Wu WC; Liu L; Ou ST; Liao W; Wang CC; Lin T; Lai CC
    Diagnostics (Basel); 2023 Jul; 13(14):. PubMed ID: 37510153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Severe ocular phenotypes in Rbp4-deficient mice in the C57BL/6 genetic background.
    Shen J; Shi D; Suzuki T; Xia Z; Zhang H; Araki K; Wakana S; Takeda N; Yamamura K; Jin S; Li Z
    Lab Invest; 2016 Jun; 96(6):680-91. PubMed ID: 26974396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum concentrations of retinol-binding protein 4 in women with and without gestational diabetes.
    Krzyzanowska K; Zemany L; Krugluger W; Schernthaner GH; Mittermayer F; Schnack C; Rahman R; Brix J; Kahn BB; Schernthaner G
    Diabetologia; 2008 Jul; 51(7):1115-22. PubMed ID: 18437353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative pharmacokinetics and pharmacodynamics of the advanced Retinol-Binding Protein 4 antagonist in dog and cynomolgus monkey.
    Racz B; Varadi A; Pearson PG; Petrukhin K
    PLoS One; 2020; 15(1):e0228291. PubMed ID: 31978148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic complement activation levels in Stargardt disease.
    Dhooge PPA; Runhart EH; Li CHZ; de Kat Angelino CM; Hoyng CB; van der Molen RG; den Hollander AI
    PLoS One; 2021; 16(6):e0253716. PubMed ID: 34170959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.